<em>Tripterygium wilfordii</em> derivative LLDT-8 targets CD2 in the treatment of rheumatoid arthritis

Li,Yuan; Qi,Wufang; Yan,Lei; Wang,Mengmeng; Zhao,Linru

doi:10.3892/br.2021.1457

Tripterygium wilfordii derivative LLDT-8 targets CD2 in the treatment of rheumatoid arthritis

Authors:
- Yuan Li
- Wufang Qi
- Lei Yan
- Mengmeng Wang
- Linru Zhao
View Affiliations

Affiliations: Department of Rheumatology and Clinical Immunology, Tianjin First Central Hospital, Tianjin 300192, P.R. China
Published online on: August 4, 2021 https://doi.org/10.3892/br.2021.1457
Article Number: 81
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Rheumatoid arthritis (RA), a chronic inflammatory synovitis systemic disease, can lead to joint deformities, loss of function and even death. The pathogenesis of RA may be related to genetics, infection and/or sex hormones; however, detailed accounts of the molecular mechanisms underlying its pathogenesis are lacking. In the present study, the synovial tissues of patients with RA and healthy individuals were analyzed to identify the pathogenic signaling pathways and key candidate genes involved in RA. Gene Ontology (GO), pathway enrichment and protein‑protein interaction analysis were further used to identify the differentially expressed genes (DEGs) and their potential roles in RA. Molecular docking was used to screen the potential candidate drugs for management of RA. Small interfering RNA was used for knockdown of the CD2 protein. A Cell Counting Kit‑8 assay was used to detect the proliferation of cells. Changes in the levels of inflammatory cytokines were detected using ELISA. A total of 279 DEGs were identified in RA; amongst these genes, 166 and 113 were upregulated and downregulated, respectively. GO analysis revealed that the upregulated DEGs were primarily enriched in the activation of the immune and adaptive immune responses, as well as the inflammatory response. The T‑cell surface antigen CD2 (CD2) was identified as the most important hub gene by selecting the most important module from the protein‑protein interaction network. Knockout of CD2 reduced the damaging effects of TNF‑α on synovial cells. Through in situ screening using computer‑aided drug design, the triptolide derivative (5R)‑5‑hydroxytriptolide (LLDT‑8) was determined to have the highest docking score based on the CD2 protein structure. Cell experiments showed that LLDT‑8 could inhibit the expression of CD2. Cell proliferation and inflammatory cytokine assays confirmed that CD2 was the direct target of LLDT‑8. Together, the results of the present study determined factors involved in the pathogenesis of RA and the important role of CD2 in this process by analyzing the DEGs in the RA process. LLDT‑8 inhibited CD2 and may thus be used to treat RA. These candidate genes and signaling pathways may serve as potential targets for the clinical treatment of RA.

View Figures

View References

1	Falconer J, Murphy AN, Young SP, Clark AR, Tiziani S, Guma M and Buckley CD: Review: Synovial Cell Metabolism and Chronic Inflammation in Rheumatoid Arthritis. Arthritis Rheumatol. 70:984–999. 2018.PubMed/NCBI View Article : Google Scholar
2	Firestein GS and McInnes IB: Immunopathogenesis of Rheumatoid Arthritis. Immunity. 46:183–196. 2017.PubMed/NCBI View Article : Google Scholar
3	Kim SY, Schneeweiss S, Liu J, Daniel GW, Chang CL, Garneau K and Solomon DH: Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther. 12(R154)2010.PubMed/NCBI View Article : Google Scholar
4	Källberg H, Ding B, Padyukov L, Bengtsson C, Rönnelid J, Klareskog L and Alfredsson L: EIRA Study Group. Smoking is a major preventable risk factor for rheumatoid arthritis: Estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis. 70:508–511. 2011.PubMed/NCBI View Article : Google Scholar
5	Klareskog L, Gregersen PK and Huizinga TW: Prevention of autoimmune rheumatic disease: State of the art and future perspectives. Ann Rheum Dis. 69:2062–2066. 2010.PubMed/NCBI View Article : Google Scholar
6	Viatte S, Plant D, Bowes J, Lunt M, Eyre S, Barton A and Worthington J: Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients. Ann Rheum Dis. 71:1984–1990. 2012.PubMed/NCBI View Article : Google Scholar
7	Hogan DB: Did Osler suffer from ‘paranoia antitherapeuticum baltimorensis’? A comparative content analysis of The Principles and Practice of Medicine and Harrison's Principles of Internal Medicine, 11th edition. CMAJ. 161:842–845. 1999.PubMed/NCBI
8	McInnes IB and Schett G: Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 389:2328–2337. 2017.PubMed/NCBI View Article : Google Scholar
9	Reis-Filho JS and Pusztai L: Gene expression profiling in breast cancer: Classification, prognostication, and prediction. Lancet. 378:1812–1823. 2011.PubMed/NCBI View Article : Google Scholar
10	Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, Jiang T and Tan L: Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. J Alzheimers Dis. 40:1017–1027. 2014.PubMed/NCBI View Article : Google Scholar
11	Shen Y, Jiang T, Wang R, He S, Guo M, Zuo J and He D: (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. BMC Complement Altern Med. 15(77)2015.PubMed/NCBI View Article : Google Scholar
12	Chen Y, Zhang L, Ni J, Wang X, Cheng J, Li Y, Zhen X, Cao T and Jia J: LLDT-8 protects against cerebral ischemia/reperfusion injury by suppressing post-stroke inflammation. J Pharmacol Sci. 131:131–137. 2016.PubMed/NCBI View Article : Google Scholar
13	Ren YX, Zhou R, Tang W, Wang WH, Li YC, Yang YF and Zuo JP: (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice. Acta Pharmacol Sin. 28:518–525. 2007.PubMed/NCBI View Article : Google Scholar
14	Xie ZC, Dang YW, Wei DM, Chen P, Tang RX, Huang Q, Liu JH and Luo DZ: Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: A comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases. OncoTargets Ther. 10:3991–4005. 2017.PubMed/NCBI View Article : Google Scholar
15	Woetzel D, Huber R, Kupfer P, Pohlers D, Pfaff M, Driesch D, Häupl T, Koczan D, Stiehl P, Guthke R, et al: Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation. Arthritis Res Ther. 16(R84)2014.PubMed/NCBI View Article : Google Scholar
16	Guo S, Liu J, Jiang T, Lee D, Wang R, Zhou X, Jin Y, Shen Y, Wang Y, Bai F, et al: (5R)-5-Hydroxytriptolide (LLDT-8) induces substantial epigenetic mediated immune response network changes in fibroblast-like synoviocytes from rheumatoid arthritis patients. Sci Rep. 9(11155)2019.PubMed/NCBI View Article : Google Scholar
17	Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43:e47. 2015.PubMed/NCBI View Article : Google Scholar
18	R Core Team: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, 2013. Available from https://www.R-project.org/.
19	Team R: RStudio: Integrated Development for R. RStudio, Inc., Boston MA, 2015. Available from URL http://www.rstudio.com.
20	Xi X, Liu N, Wang Q, Chu Y, Yin Z, Ding Y and Lu Y: ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma. Cell Death Dis. 10(757)2019.PubMed/NCBI View Article : Google Scholar
21	Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. 2003.PubMed/NCBI View Article : Google Scholar
22	Xi X, Chu Y, Liu N, Wang Q, Yin Z, Lu Y and Chen Y: Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma. J Transl Med. 17(129)2019.PubMed/NCBI View Article : Google Scholar
23	Zhong W, Sun B, Gao W, Qin Y, Zhang H, Huai L, Tang Y, Liang Y, He L, Zhang X, et al: Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction. EBioMedicine. 37:246–258. 2018.PubMed/NCBI View Article : Google Scholar
24	Zhong W, Yang W, Qin Y, Gu W, Xue Y, Tang Y, Xu H, Wang H, Zhang C, Wang C, et al: 6-Gingerol stabilized the p-VEGFR2/VE-cadherin/β-catenin/actin complex promotes microvessel normalization and suppresses tumor progression. J Exp Clin Cancer Res. 38(285)2019.PubMed/NCBI View Article : Google Scholar
25	Yu G, Wang LG, Han Y and He QY: clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 16:284–287. 2012.PubMed/NCBI View Article : Google Scholar
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
27	Scardoni G, Petterlini M and Laudanna C: Analyzing biological network parameters with CentiScaPe. Bioinformatics. 25:2857–2859. 2009.PubMed/NCBI View Article : Google Scholar
28	Bader GD and Hogue CW: An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 4(2)2003.PubMed/NCBI View Article : Google Scholar
29	Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al: STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.PubMed/NCBI View Article : Google Scholar
30	Bodian DL, Jones EY, Harlos K, Stuart DI and Davis SJ: Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution. Structure. 2:755–766. 1994.PubMed/NCBI View Article : Google Scholar
31	Zhong W, Liu P, Zhang Q, Li D and Lin J: Structure-based QSAR, molecule design and bioassays of protease-activated receptor 1 inhibitors. J Biomol Struct Dyn. 35:2853–2867. 2017.PubMed/NCBI View Article : Google Scholar
32	DeLano WL: Pymol: An open-source molecular graphics tool. CCP4 Newsletter on protein crystallography. 40:82–92. 2002.
33	Reimand J, Isserlin R, Voisin V, Kucera M, Tannus-Lopes C, Rostamianfar A, Wadi L, Meyer M, Wong J, Xu C, et al: Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc. 14:482–517. 2019.PubMed/NCBI View Article : Google Scholar
34	Catrina AI, Joshua V, Klareskog L and Malmström V: Mechanisms involved in triggering rheumatoid arthritis. Immunol Rev. 269:162–174. 2016.PubMed/NCBI View Article : Google Scholar
35	Glaab E, Baudot A, Krasnogor N and Valencia A: TopoGSA: Network topological gene set analysis. Bioinformatics. 26:1271–1272. 2010.PubMed/NCBI View Article : Google Scholar
36	Bao R, Huang L, Andrade J, Tan W, Kibbe WA, Jiang H and Feng G: Review of current methods, applications, and data management for the bioinformatics analysis of whole exome sequencing. Cancer Inform. 13 (Suppl 2):67–82. 2014.PubMed/NCBI View Article : Google Scholar
37	Yang JJ, Ye Y, Carroll A, Yang W and Lee HW: Structural biology of the cell adhesion protein CD2: Alternatively folded states and structure-function relation. Curr Protein Pept Sci. 2:1–17. 2001.PubMed/NCBI View Article : Google Scholar
38	Watzl C and Long EO: Signal transduction during activation and inhibition of natural killer cells. Curr Protoc Immunol. 11(17)2010.PubMed/NCBI View Article : Google Scholar
39	James JR and Vale RD: Biophysical mechanism of T-cell receptor triggering in a reconstituted system. Nature. 487:64–69. 2012.PubMed/NCBI View Article : Google Scholar
40	Wong KF, Yuan Y and Luk JM: Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents. Clin Exp Pharmacol Physiol. 39:311–320. 2012.PubMed/NCBI View Article : Google Scholar
41	Bao J and Dai SM: A Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: Mechanism, efficacy, and safety. Rheumatol Int. 31:1123–1129. 2011.PubMed/NCBI View Article : Google Scholar